Pembrolizumab as first line treatment of Merkel cell carcinoma patients–a case series of patients with various co-morbidities

Tessa Bystrup Boyles, Mette Schødt, Helle Westergren Hendel, Anders Krarup-Hansen, Niels Junker^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Research › peer-review

6 Citations (Scopus)

Access to Document

@article{29747654d7b6427baa7d5e993f337341,

title = "Pembrolizumab as first line treatment of Merkel cell carcinoma patients–a case series of patients with various co-morbidities",

author = "{Bystrup Boyles}, Tessa and Mette Sch{\o}dt and Hendel, {Helle Westergren} and Anders Krarup-Hansen and Niels Junker",

year = "2020",

doi = "10.1080/0284186X.2020.1747637",

language = "English",

volume = "59",

pages = "793--796",

journal = "Acta Oncologica",

issn = "1100-1704",

publisher = "Taylor & Francis",

number = "7",

}

TY - JOUR

T1 - Pembrolizumab as first line treatment of Merkel cell carcinoma patients–a case series of patients with various co-morbidities

AU - Bystrup Boyles, Tessa

AU - Schødt, Mette

AU - Hendel, Helle Westergren

AU - Krarup-Hansen, Anders

AU - Junker, Niels

PY - 2020

Y1 - 2020

U2 - 10.1080/0284186X.2020.1747637

DO - 10.1080/0284186X.2020.1747637

M3 - Letter

C2 - 32285728

AN - SCOPUS:85083569601

VL - 59

SP - 793

EP - 796

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 7

ER -